Sort
25,944 grants matching “neurodegeneration”
METABOTROPIC GLUTAMATE RECEPTORS IN NEURODEGENERATION
$414,250Massachusetts General Hospital · R37 · FY2004 · AG
METABOTROPIC GLUTAMATE RECEPTORS IN NEURODEGENERATION
$414,250Massachusetts General Hospital · R37 · FY2003 · AG
Gene-Environment Interactions in Neurodegeneration: Role of Efflux Transporters
$414,199Jason R Richardson · Northeast Ohio Medical University · R01 · FY2017 · ES
Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome
$414,172Yatin M Vyas · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · AI
Cognitive Neuroplasticity and Recovery of Function Following Brain Damage
$414,106Jordan Grafman · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Neurogenetics of TS-Paralytic Mutants in Drosophila
$413,973University Of Wisconsin Madison · R01 · FY2003 · NS
Interleukin-6 and Retinal Ganglion Cell Degeneration in Glaucoma
$413,900Rebecca M Sappington · Wake Forest University Health Sciences · R01 · FY2020 · EY
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$413,819Matthew D Disney · Scripps Florida · P01 · FY2021 · NS
Fluid Biomarker Core
$413,742Kiran Bhaskar · University Of New Mexico Health Scis Ctr · P30 · FY2024 · AG
Dissecting the Molecular Link Between Stroke, Actin, and Alzheimer's Disease
$413,729Claudia Fallini · University Of Rhode Island · R21 · FY2023 · NS
Cognitive impairment in the DPPOS cohort and its neuropathologic, neurophysiologic, sociodemographic, and behavioral correlates
$413,724James McCallum Noble · Columbia University Health Sciences · U19 · FY2022 · AG
Newly Identified Regulator of Neuronal Differentiation
$413,723Univ Of Massachusetts Med Sch Worcester · R01 · FY2004 · NS
Discovering How Cu(II)/Zn(II) Uptake by the Prion Protein Controls Structure, Function and Neurotoxicity
$413,717Glenn L Millhauser · University Of California Santa Cruz · R35 · FY2025 · GM
Polyglutamine Conformation and Neurodegeneration
$413,635Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2010 · NS
The PPD (Parkin-PINK1-DJ-1) E3 Ligase Complex and Neurodegeneration
$413,635Zhuohua Zhang · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · NS
Mechanisms of Huntingtin-induced Neurodegeneration
$413,635Steven M Finkbeiner · J. David Gladstone Institutes · R01 · FY2014 · NS
4D Shape Analysis for Modeling Spatiotemporal Change Trajectories in Huntington's
$413,478Guido Gerig · University Of Utah · U01 · FY2014 · NS
Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression
$413,294Marie Ynez Davis · Seattle Inst For Biomedical/Clinical Res · R01 · FY2022 · NS
Role of midlife cardiovascular disease on Alzheimerâs Pathology and cerebrovascular reactivity in the young-old.
$413,290Ann D. Cohen · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AG
Biology of Parkin and It's Role in Parkinson's Disease
$413,100Ted M. Dawson · Johns Hopkins University · P50 · FY2014 · NS
LRRK2 Biology in Parkinson's Disease
$413,100Valina L. Dawson · Johns Hopkins University · P50 · FY2014 · NS
HDAC1 Activating Compounds as Therapeutics for Neurodegenerative Disorders
$413,058Li-Huei Tsai · Massachusetts Institute Of Technology · RC1 · FY2009 · AG
Core E: Imaging
$413,006Tammie Lee Smith Benzinger · Washington University · P01 · FY2018 · AG
Modeling and Analysis of Roles of Yeast Sphingolipids
$412,983Yusuf Awni Hannun · State University New York Stony Brook · R01 · FY2012 · GM
Cell Specific RIPK3 signaling after traumatic brain injury in mice
$412,956Michael J Whalen · Massachusetts General Hospital · R01 · FY2023 · NS